Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Consensus Rating of "Hold" by Brokerages

Prestige Consumer Healthcare Inc. (NYSE:PBH - Get Free Report) has been assigned an average rating of "Hold" from the seven analysts that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, two have given a hold recommendation and four have issued a buy recommendation on the company. The average 12 month price target among brokerages that have covered the stock in the last year is $94.80.

Several brokerages have commented on PBH. Zacks Research downgraded Prestige Consumer Healthcare from a "hold" rating to a "strong sell" rating in a report on Thursday, September 4th. Wall Street Zen downgraded Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday, August 9th. Sidoti raised Prestige Consumer Healthcare from a "neutral" rating to a "buy" rating and set a $80.00 price objective on the stock in a research note on Wednesday, September 24th. Weiss Ratings reissued a "hold (c)" rating on shares of Prestige Consumer Healthcare in a research note on Saturday, September 27th. Finally, Canaccord Genuity Group dropped their price objective on Prestige Consumer Healthcare from $105.00 to $100.00 and set a "buy" rating on the stock in a research note on Friday, August 8th.

Prestige Consumer Healthcare Trading Up 2.0%

Shares of PBH opened at $64.07 on Friday. Prestige Consumer Healthcare has a 52-week low of $61.28 and a 52-week high of $90.04. The business's fifty day moving average is $66.49 and its 200-day moving average is $76.91. The company has a debt-to-equity ratio of 0.55, a quick ratio of 2.99 and a current ratio of 4.38. The firm has a market cap of $3.15 billion, a price-to-earnings ratio of 15.04, a PEG ratio of 2.02 and a beta of 0.44.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last issued its quarterly earnings data on Thursday, August 7th. The company reported $0.95 earnings per share for the quarter, missing analysts' consensus estimates of $1.01 by ($0.06). The firm had revenue of $249.53 million for the quarter, compared to the consensus estimate of $260.71 million. Prestige Consumer Healthcare had a return on equity of 12.69% and a net margin of 19.02%.The company's revenue was down 6.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.90 EPS. Prestige Consumer Healthcare has set its FY 2026 guidance at 4.500-4.580 EPS. Equities analysts anticipate that Prestige Consumer Healthcare will post 4.5 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the company. UMB Bank n.a. raised its stake in Prestige Consumer Healthcare by 81.8% during the 2nd quarter. UMB Bank n.a. now owns 320 shares of the company's stock worth $26,000 after buying an additional 144 shares during the period. Caitong International Asset Management Co. Ltd increased its holdings in Prestige Consumer Healthcare by 312.5% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 330 shares of the company's stock worth $26,000 after purchasing an additional 250 shares in the last quarter. Maseco LLP bought a new stake in Prestige Consumer Healthcare during the 2nd quarter worth approximately $27,000. Opal Wealth Advisors LLC bought a new stake in Prestige Consumer Healthcare during the 1st quarter worth approximately $38,000. Finally, Elevation Point Wealth Partners LLC bought a new stake in Prestige Consumer Healthcare during the 2nd quarter worth approximately $46,000. 99.95% of the stock is owned by institutional investors and hedge funds.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.